500 related articles for article (PubMed ID: 16166334)
1. High-level coexpression of JAG1 and NOTCH1 is observed in human breast cancer and is associated with poor overall survival.
Reedijk M; Odorcic S; Chang L; Zhang H; Miller N; McCready DR; Lockwood G; Egan SE
Cancer Res; 2005 Sep; 65(18):8530-7. PubMed ID: 16166334
[TBL] [Abstract][Full Text] [Related]
2. Spatial localization of the JAG1/Notch1/osteopontin cascade modulates extrahepatic metastasis in hepatocellular carcinoma.
Xue TC; Zou JH; Chen RX; Cui JF; Tang ZY; Ye SL
Int J Oncol; 2014 Nov; 45(5):1883-90. PubMed ID: 25176314
[TBL] [Abstract][Full Text] [Related]
3. High-level JAG1 mRNA and protein predict poor outcome in breast cancer.
Dickson BC; Mulligan AM; Zhang H; Lockwood G; O'Malley FP; Egan SE; Reedijk M
Mod Pathol; 2007 Jun; 20(6):685-93. PubMed ID: 17507991
[TBL] [Abstract][Full Text] [Related]
4. Association of high levels of Jagged-1 and Notch-1 expression with poor prognosis in head and neck cancer.
Lin JT; Chen MK; Yeh KT; Chang CS; Chang TH; Lin CY; Wu YC; Su BW; Lee KD; Chang PJ
Ann Surg Oncol; 2010 Nov; 17(11):2976-83. PubMed ID: 20517681
[TBL] [Abstract][Full Text] [Related]
5. [Notch signaling in human breast cancer].
Dong XB; Ji CY; Ma DX; Ma R; Zang SL; Yu HQ; Guo DM
Zhonghua Zhong Liu Za Zhi; 2007 Jun; 29(6):425-8. PubMed ID: 17974275
[TBL] [Abstract][Full Text] [Related]
6. Notch-1 and notch-4 receptors as prognostic markers in breast cancer.
Yao K; Rizzo P; Rajan P; Albain K; Rychlik K; Shah S; Miele L
Int J Surg Pathol; 2011 Oct; 19(5):607-13. PubMed ID: 20444726
[TBL] [Abstract][Full Text] [Related]
7. Cyclin D1 is a direct target of JAG1-mediated Notch signaling in breast cancer.
Cohen B; Shimizu M; Izrailit J; Ng NF; Buchman Y; Pan JG; Dering J; Reedijk M
Breast Cancer Res Treat; 2010 Aug; 123(1):113-24. PubMed ID: 19915977
[TBL] [Abstract][Full Text] [Related]
8. Notch1 ligand signaling pathway activated in cervical cancer: poor prognosis with high-level JAG1/Notch1.
Yousif NG; Sadiq AM; Yousif MG; Al-Mudhafar RH; Al-Baghdadi JJ; Hadi N
Arch Gynecol Obstet; 2015 Oct; 292(4):899-904. PubMed ID: 25842263
[TBL] [Abstract][Full Text] [Related]
9. JAG1 expression is associated with a basal phenotype and recurrence in lymph node-negative breast cancer.
Reedijk M; Pinnaduwage D; Dickson BC; Mulligan AM; Zhang H; Bull SB; O'Malley FP; Egan SE; Andrulis IL
Breast Cancer Res Treat; 2008 Oct; 111(3):439-48. PubMed ID: 17990101
[TBL] [Abstract][Full Text] [Related]
10. Notch1 pathway in adrenocortical carcinomas: correlations with clinical outcome.
Ronchi CL; Sbiera S; Altieri B; Steinhauer S; Wild V; Bekteshi M; Kroiss M; Fassnacht M; Allolio B
Endocr Relat Cancer; 2015 Aug; 22(4):531-43. PubMed ID: 25979380
[TBL] [Abstract][Full Text] [Related]
11. Association of low expression of notch-1 and jagged-1 in human papillary bladder cancer and shorter survival.
Shi TP; Xu H; Wei JF; Ai X; Ma X; Wang BJ; Ju ZH; Zhang GX; Wang C; Wu ZQ; Zhang X
J Urol; 2008 Jul; 180(1):361-6. PubMed ID: 18499162
[TBL] [Abstract][Full Text] [Related]
12. A study on Notch signaling in human breast cancer.
Zang S; Ji Ch; Qu X; Dong X; Ma D; Ye J; Ma R; Dai J; Guo D
Neoplasma; 2007; 54(4):304-10. PubMed ID: 17822320
[TBL] [Abstract][Full Text] [Related]
13. Activation of Notch signaling in human tongue carcinoma.
Zhang TH; Liu HC; Zhu LJ; Chu M; Liang YJ; Liang LZ; Liao GQ
J Oral Pathol Med; 2011 Jan; 40(1):37-45. PubMed ID: 20819128
[TBL] [Abstract][Full Text] [Related]
14. Protein and mRNA expression of notch pathway components in operable tumors of patients with laryngeal cancer.
Krikelis D; Kotoula V; Bobos M; Fountzilas E; Markou K; Karasmanis I; Angouridakis N; Vlachtsis K; Kalogeras KT; Nikolaou A; Fountzilas G
Anticancer Res; 2014 Nov; 34(11):6495-503. PubMed ID: 25368251
[TBL] [Abstract][Full Text] [Related]
15. Profiling immunohistochemical expression of NOTCH1-3, JAGGED1, cMET, and phospho-MAPK in 100 carcinomas of unknown primary.
Krikelis D; Pentheroudakis G; Goussia A; Siozopoulou V; Bobos M; Petrakis D; Stoyianni A; Golfinopoulos V; Cervantes A; Ciuleanu T; Fountzilas G; Malamou-Mitsi V; Pavlidis N
Clin Exp Metastasis; 2012 Aug; 29(6):603-14. PubMed ID: 22526456
[TBL] [Abstract][Full Text] [Related]
16. NOTCH1, NOTCH3, NOTCH4, and JAG2 protein levels in human endometrial cancer.
Sasnauskienė A; Jonušienė V; Krikštaponienė A; Butkytė S; Dabkevičienė D; Kanopienė D; Kazbarienė B; Didžiapetrienė J
Medicina (Kaunas); 2014; 50(1):14-8. PubMed ID: 25060200
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of Notch signalling molecules and their involvement in the invasiveness of endometrial carcinoma cells.
Mitsuhashi Y; Horiuchi A; Miyamoto T; Kashima H; Suzuki A; Shiozawa T
Histopathology; 2012 Apr; 60(5):826-37. PubMed ID: 22348356
[TBL] [Abstract][Full Text] [Related]
18. BRCA1 is a key regulator of breast differentiation through activation of Notch signalling with implications for anti-endocrine treatment of breast cancers.
Buckley NE; Nic An tSaoir CB; Blayney JK; Oram LC; Crawford NT; D'Costa ZC; Quinn JE; Kennedy RD; Harkin DP; Mullan PB
Nucleic Acids Res; 2013 Oct; 41(18):8601-14. PubMed ID: 23863842
[TBL] [Abstract][Full Text] [Related]
19. [Expression changes of Notch-related genes during the differentiation of human mesenchymal stem cells into neurons].
Xing Y; Bai RY; Yan WH; Han XF; Duan P; Xu Y; Fan ZG
Sheng Li Xue Bao; 2007 Jun; 59(3):267-72. PubMed ID: 17579779
[TBL] [Abstract][Full Text] [Related]
20. Plasminogen activator uPA is a direct transcriptional target of the JAG1-Notch receptor signaling pathway in breast cancer.
Shimizu M; Cohen B; Goldvasser P; Berman H; Virtanen C; Reedijk M
Cancer Res; 2011 Jan; 71(1):277-86. PubMed ID: 21199807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
